Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.
about
The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and TreatmentCytokine-Induced Modulation of Colorectal CancerImmune cell interplay in colorectal cancer prognosisAdoptive T-cell therapy for cancer: The era of engineered T cellsInitiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells.Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumorsHLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.Fundamental Principles of Cancer Biology: Does it have relevance to the perioperative period?OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancerDistribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastasesCIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer ImmunotherapyTumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells.Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling.Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells.Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion.The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?Checkpoint inhibition for colorectal cancer: progress and possibilities.IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8.IL-10: Expanding the Immune Oncology Horizon.Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women.[Disease-modifying antirheumatic drugs in rheumatoid arthritis patients with a history of colorectal cancer].MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cellsTumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma.The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment.Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection.Cordycepin and a preparation from Cordyceps militaris inhibit malignant transformation and proliferation by decreasing EGFR and IL-17RA signaling in a murine oral cancer model.The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer.CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.Strategy to targeting the immune resistance and novel therapy in colorectal cancer.The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction.Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New EvidencesStem and immune cells in colorectal primary tumour: Number and function of subsets may diagnose metastasis
P2860
Q26745580-885718F1-BA4D-447F-85D2-67E037A0E5D5Q26752374-3D5E5078-8D59-4494-8AEF-5208828C4F92Q26781453-DE49E3AC-5B75-4C1F-A36F-31ABE7DF66E7Q26800611-B4419A3C-157D-486E-915A-C409377E57F3Q33711746-FE126116-69FC-4643-A092-5A9A3A58A1AFQ35673240-790CE3DA-3677-493F-A8D0-2841456F16B6Q35860201-FE6BF98E-B3F7-47D1-95A0-4BA9A91FDC34Q36062109-480B6CFF-27C9-4D63-B70A-2632CA4A22FDQ36545813-FACC97F3-9F6B-4CA5-B76F-BB228C3AB7CBQ36562180-F78CCD2C-35E2-46C9-9270-6CF154EE6B07Q37130209-F5832DC5-C598-4D05-991B-1625D39AF9CBQ37616487-2A79613E-5603-4809-A8F5-3E935466F908Q37687316-4E010030-E54A-486D-B3E6-D968C33B4249Q37716516-BD284F54-2759-400D-811F-09D2384BC3DBQ38364298-8AED1D64-4328-4179-98C9-480750BE7020Q38788951-CC15D4D2-C9CF-4DD6-A7D2-1116AF9BEE12Q38835601-307A0650-6A9A-4F90-ACA5-3234D08E052DQ38838641-52145229-F471-4A52-815D-EAF3C34124F9Q39294822-46050D3E-BBAE-45C4-90BC-CF3983F78C41Q39542382-D9B3B273-8933-408F-A4CC-536AC60C035EQ39668561-05747BCF-E768-4EF6-961F-CA72DDEEF94EQ40217856-9CCF0A7C-D02E-457F-AB14-4A7F8641C370Q40423175-2E597557-0AAC-475A-986E-A99FEA12298AQ40965334-145A25C4-954E-4A4B-9590-9E28F323ABCDQ40987678-9003980A-18E2-4C5B-8753-2AB8509160ADQ41316816-D94A49E7-D2BF-495E-A400-E11315389A20Q41866457-A3DE4F67-0FD9-4DA4-AA06-3D49A6CD25C6Q42700802-14C0A147-033A-41CB-89F2-F615C70C6E99Q47139326-069C5F9D-EB28-45DE-95EC-4D8463A10C32Q47320798-BF1F25D4-451A-4604-B429-C99142932B72Q47581436-E51EECBC-15B2-4597-97A6-956E415C7A31Q48331916-EBC1526D-0ADE-441F-AC20-44B745281318Q51018817-853E85CF-8F2B-4CF7-B958-664CA79E51F1Q52320729-DE386DA6-1CF4-4E03-9532-03F92077F03EQ52679182-69DC2B63-1D18-43AE-94C6-14AD9745F6FEQ57191808-9211CC82-CB3F-4653-AE5A-169FD419D1CCQ58199154-F207FDA2-A994-4D53-B424-7245754ABF50
P2860
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumor-specific cytotoxic T lym ...... ctal cancer patient prognosis.
@ast
Tumor-specific cytotoxic T lym ...... ctal cancer patient prognosis.
@en
type
label
Tumor-specific cytotoxic T lym ...... ctal cancer patient prognosis.
@ast
Tumor-specific cytotoxic T lym ...... ctal cancer patient prognosis.
@en
prefLabel
Tumor-specific cytotoxic T lym ...... ctal cancer patient prognosis.
@ast
Tumor-specific cytotoxic T lym ...... ctal cancer patient prognosis.
@en
P2093
P2860
P921
P356
P1476
Tumor-specific cytotoxic T lym ...... ctal cancer patient prognosis.
@en
P2093
Andreas Bonertz
Axel Benner
Christina Gossmann
Christoph Reissfelder
Dirk Jäger
Khashayarsha Khazaie
Maral Saadati
Mario Grimm
Marion Braun
Moritz Koch
P2860
P304
P356
10.1172/JCI74894
P407
P577
2014-12-22T00:00:00Z